Market Overview:
The global hypoactive sexual desire disorder treatment market is expected to exhibit a CAGR of 4.5% during 2022-2027.
Hypoactive sexual desire disorder (HSDD) refers to a medical condition with low libido or sexual desire in women. The sexual dysfunction in HSDD is primarily associated with hyperfunction inhibition and hypofunctional excitation regulated by neuromodulators in the brain. Furthermore, several physical conditions are also related to HSDD, including anxiety, depression, diabetes, urinary incontinence, menopause, multiple sclerosis, etc. HSDD treatment mainly includes psychotherapy or pharmacotherapy. Psychotherapy utilizes cognitive behavioral therapy, which offers counseling sessions with a sex therapist, whereas pharmacotherapy comprises of treatment with several drugs, such as Buspirone, Bupropion, Testosterone, Flibanserin, etc.
The rising working women population coupled with their hectic work schedules often result in low libido conditions, thereby augmenting the demand for HSDD treatment. Furthermore, the high prevalence of numerous lifestyle ailments, such as anxiety, stress, depression, prolonged fatigue, irregular menstruation, etc., is also catalyzing the incidences of HSDD. Additionally, diminished libido can also be a side-effect of certain chemical-based drugs that may further lead imbalance of neurotransmitters in the brain, causing HSDD. Moreover, the rising aging women population, premature menopause, and low self-esteem towards one’s physical appearance is also associated with low libido in women, thereby driving the demand for HSDD treatment. Besides this, the reducing stigma associated with HSDD coupled with the growing awareness towards the disease diagnosis and effective treatment is further propelling the market growth. The emergence of the PLISSIT model (Permission, Limited Information, Specific Suggestions, and Intensive Therapy) aids in the initial screening of HSDD. Furthermore, the faster drug approvals for treating HSDD along with the increasing investments in new drug development activities are further catalyzing the market growth. For instance, the U.S. Food and Drug Administration (FDA) approved ‘Vyleesi’ that activates melanocortin receptors for improving sexual desire in women.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global hypoactive sexual desire disorder treatment market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on therapy, distribution channel and application.
Breakup by Therapy:
- Buspirone
- Bupropion
- Testosterone
- Flibanserin
- Bremelanotide
- Cognitive Behavior Therapy
Breakup by Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Breakup by Application:
Breakup by Region:
- North America
- Europe
- United Kingdom
- Germany
- France
- Spain
- Italy
- Russia
- Others
- Asia Pacific
- China
- Japan
- India
- South Korea
- Others
- Middle East and Africa
- Saudi Arabia
- Iran
- Turkey
- Others
- Latin America
Competitive Landscape:
The competitive landscape of the industry has also been examined with some of the key players being Allergan Plc, AMAG Pharmaceuticals, Inc., Emotional Brain BV, Endoceutics, Inc., GlaxoSmithKline Plc, Ovoca Bio Plc, Pivot Pharmaceuticals, Inc., Palatin Technologies, Inc., S1 Biopharma, Inc., and Sprout Pharmaceuticals, Inc.
Report Coverage:
| Report Features |
Details |
|---|
| Base Year of the Analysis |
2021 |
| Historical Period |
2016-2021 |
| Forecast Period |
2022-2027 |
| Units |
US$ Billion |
| Segment Coverage |
Therapy, Distribution Channel, Application, Region |
| Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
| Countries Covered |
United States, Canada, United Kingdom, Germany, France, Spain, Italy, Russia, China, Japan, India, South Korea, Saudi Arabia, Iran, Turkey, Brazil, Mexico |
| Companies Covered |
Allergan Plc, AMAG Pharmaceuticals, Inc., Emotional Brain BV, Endoceutics, Inc., GlaxoSmithKline Plc, Ovoca Bio Plc, Pivot Pharmaceuticals, Inc., Palatin Technologies, Inc., S1 Biopharma, Inc., and Sprout Pharmaceuticals, Inc. |
| Customization Scope |
10% Free Customization |
| Report Price and Purchase Option |
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499 |
| Post-Sale Analyst Support |
10-12 Weeks |
| Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the global hypoactive sexual desire disorder treatment market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global hypoactive sexual desire disorder treatment market?
- What are the key regional markets?
- What is the breakup of the market based on the therapy?
- What is the breakup of the market based on the distribution channel?
- What is the breakup of the market based on the application?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global hypoactive sexual desire disorder treatment market and who are the key players?
- What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Hypoactive Sexual Desire Disorder Treatment (HSDDT) Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Therapy
6.1 Buspirone
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Bupropion
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Testosterone
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Flibanserin
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Bremelanotide
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Cognitive Behavior Therapy
6.6.1 Market Trends
6.6.2 Market Forecast
7 Market Breakup by Distribution Channel
7.1 Hospital Pharmacies
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Retail Pharmacies
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Online Pharmacies
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by Application
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Clinics
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Europe
9.2.1 United Kingdom
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Germany
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 France
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 Spain
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Italy
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Russia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Asia Pacific
9.3.1 China
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 Japan
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 India
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 South Korea
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Others
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.4 Middle East and Africa
9.4.1 Saudi Arabia
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Iran
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Turkey
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.4.4 Others
9.4.4.1 Market Trends
9.4.4.2 Market Forecast
9.5 Latin America
9.5.1 Brazil
9.5.1.1 Market Trends
9.5.1.2 Market Forecast
9.5.2 Mexico
9.5.2.1 Market Trends
9.5.2.2 Market Forecast
9.5.3 Others
9.5.3.1 Market Trends
9.5.3.2 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Competitive Landscape
13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
13.3.1 Allergan Plc
13.3.1.1 Company Overview
13.3.1.2 Product Portfolio
13.3.2 AMAG Pharmaceuticals, Inc.
13.3.2.1 Company Overview
13.3.2.2 Product Portfolio
13.3.2.3 Financials
13.3.2.4 SWOT Analysis
13.3.3 Emotional Brain BV
13.3.3.1 Company Overview
13.3.3.2 Product Portfolio
13.3.4 Endoceutics, Inc.
13.3.4.1 Company Overview
13.3.4.2 Product Portfolio
13.3.5 GlaxoSmithKline Plc
13.3.5.1 Company Overview
13.3.5.2 Product Portfolio
13.3.5.3 Financials
13.3.5.4 SWOT Analysis
13.3.6 Ovoca Bio Plc
13.3.6.1 Company Overview
13.3.6.2 Product Portfolio
13.3.7 Pivot Pharmaceuticals, Inc.
13.3.7.1 Company Overview
13.3.7.2 Product Portfolio
13.3.8 Palatin Technologies, Inc.
13.3.8.1 Company Overview
13.3.8.2 Product Portfolio
13.3.8.3 Financials
13.3.8.4 SWOT Analysis
13.3.9 S1 Biopharma, Inc
13.3.9.1 Company Overview
13.3.9.2 Product Portfolio
13.3.9.3 Financials
13.3.10 Sprout Pharmaceuticals, Inc.
13.3.10.1 Company Overview
13.3.10.2 Product Portfolio
List of Figures
Figure 1: Global: Hypoactive Sexual Desire Disorder Treatment Market: Major Drivers and Challenges
Figure 2: Global: Hypoactive Sexual Desire Disorder Treatment Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Hypoactive Sexual Desire Disorder Treatment Market: Breakup by Therapy (in %), 2021
Figure 4: Global: Hypoactive Sexual Desire Disorder Treatment Market: Breakup by Distribution Channel (in %), 2021
Figure 5: Global: Hypoactive Sexual Desire Disorder Treatment Market: Breakup by Application (in %), 2021
Figure 6: Global: Hypoactive Sexual Desire Disorder Treatment Market: Breakup by Region (in %), 2021
Figure 7: Global: Hypoactive Sexual Desire Disorder Treatment Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 8: Global: Hypoactive Sexual Desire Disorder Treatment (Buspirone) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Hypoactive Sexual Desire Disorder Treatment (Buspirone) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Hypoactive Sexual Desire Disorder Treatment (Bupropion) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Hypoactive Sexual Desire Disorder Treatment (Bupropion) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Hypoactive Sexual Desire Disorder Treatment (Testosterone) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Hypoactive Sexual Desire Disorder Treatment (Testosterone) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Hypoactive Sexual Desire Disorder Treatment (Flibanserin) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Hypoactive Sexual Desire Disorder Treatment (Flibanserin) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Hypoactive Sexual Desire Disorder Treatment (Bremelanotide) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Hypoactive Sexual Desire Disorder Treatment (Bremelanotide) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Hypoactive Sexual Desire Disorder Treatment (Cognitive Behavior Therapy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Hypoactive Sexual Desire Disorder Treatment (Cognitive Behavior Therapy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Hypoactive Sexual Desire Disorder Treatment (Hospital Pharmacies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Hypoactive Sexual Desire Disorder Treatment (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Hypoactive Sexual Desire Disorder Treatment (Retail Pharmacies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Hypoactive Sexual Desire Disorder Treatment (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Hypoactive Sexual Desire Disorder Treatment (Online Pharmacies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Hypoactive Sexual Desire Disorder Treatment (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Hypoactive Sexual Desire Disorder Treatment (Hospitals) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Hypoactive Sexual Desire Disorder Treatment (Hospitals) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Global: Hypoactive Sexual Desire Disorder Treatment (Clinics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Global: Hypoactive Sexual Desire Disorder Treatment (Clinics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: Global: Hypoactive Sexual Desire Disorder Treatment (Other Applications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: Global: Hypoactive Sexual Desire Disorder Treatment (Other Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: North America: Hypoactive Sexual Desire Disorder Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: North America: Hypoactive Sexual Desire Disorder Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: United States: Hypoactive Sexual Desire Disorder Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: United States: Hypoactive Sexual Desire Disorder Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: Canada: Hypoactive Sexual Desire Disorder Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: Canada: Hypoactive Sexual Desire Disorder Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: Europe: Hypoactive Sexual Desire Disorder Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: Europe: Hypoactive Sexual Desire Disorder Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: United Kingdom: Hypoactive Sexual Desire Disorder Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: United Kingdom: Hypoactive Sexual Desire Disorder Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: Germany: Hypoactive Sexual Desire Disorder Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: Germany: Hypoactive Sexual Desire Disorder Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: France: Hypoactive Sexual Desire Disorder Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: France: Hypoactive Sexual Desire Disorder Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Spain: Hypoactive Sexual Desire Disorder Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Spain: Hypoactive Sexual Desire Disorder Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Italy: Hypoactive Sexual Desire Disorder Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Italy: Hypoactive Sexual Desire Disorder Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Russia: Hypoactive Sexual Desire Disorder Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Russia: Hypoactive Sexual Desire Disorder Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: Others: Hypoactive Sexual Desire Disorder Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: Others: Hypoactive Sexual Desire Disorder Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: Asia Pacific: Hypoactive Sexual Desire Disorder Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: Asia Pacific: Hypoactive Sexual Desire Disorder Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: China: Hypoactive Sexual Desire Disorder Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: China: Hypoactive Sexual Desire Disorder Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Japan: Hypoactive Sexual Desire Disorder Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Japan: Hypoactive Sexual Desire Disorder Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: India: Hypoactive Sexual Desire Disorder Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: India: Hypoactive Sexual Desire Disorder Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: South Korea: Hypoactive Sexual Desire Disorder Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: South Korea: Hypoactive Sexual Desire Disorder Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Others: Hypoactive Sexual Desire Disorder Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Others: Hypoactive Sexual Desire Disorder Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Middle East and Africa: Hypoactive Sexual Desire Disorder Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Middle East and Africa: Hypoactive Sexual Desire Disorder Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Saudi Arabia: Hypoactive Sexual Desire Disorder Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Saudi Arabia: Hypoactive Sexual Desire Disorder Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Iran: Hypoactive Sexual Desire Disorder Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Iran: Hypoactive Sexual Desire Disorder Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Turkey: Hypoactive Sexual Desire Disorder Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Turkey: Hypoactive Sexual Desire Disorder Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Others: Hypoactive Sexual Desire Disorder Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Others: Hypoactive Sexual Desire Disorder Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 76: Latin America: Hypoactive Sexual Desire Disorder Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 77: Latin America: Hypoactive Sexual Desire Disorder Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 78: Brazil: Hypoactive Sexual Desire Disorder Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 79: Brazil: Hypoactive Sexual Desire Disorder Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 80: Mexico: Hypoactive Sexual Desire Disorder Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 81: Mexico: Hypoactive Sexual Desire Disorder Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 82: Others: Hypoactive Sexual Desire Disorder Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 83: Others: Hypoactive Sexual Desire Disorder Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 84: Global: Hypoactive Sexual Desire Disorder Treatment Industry: SWOT Analysis
Figure 85: Global: Hypoactive Sexual Desire Disorder Treatment Industry: Value Chain Analysis
Figure 86: Global: Hypoactive Sexual Desire Disorder Treatment Industry: Porter’s Five Forces Analysis
List of Tables
Table 1: Global: Hypoactive Sexual Desire Disorder Treatment Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Hypoactive Sexual Desire Disorder Treatment Market Forecast: Breakup by Therapy (in Million US$), 2022-2027
Table 3: Global: Hypoactive Sexual Desire Disorder Treatment Market Forecast: Breakup by Distribution Channel (in Million US$), 2022-2027
Table 4: Global: Hypoactive Sexual Desire Disorder Treatment Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 5: Global: Hypoactive Sexual Desire Disorder Treatment Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Hypoactive Sexual Desire Disorder Treatment Market: Competitive Structure
Table 7: Global: Hypoactive Sexual Desire Disorder Treatment Market: Key Players